Skip to content
Our Focus
About Us
Resources
Browse our latest resources
Newsroom
Keep up with our latest news.
Publications
Learn more about our science.
Trail Notes
Insights from our leadership team
Cliffs Notes
Downloadable, infographics and more.
Careers
Contact
Investors
Careers
CLINICALTRIALS.GOV
The Crestone Study
Seribantumab
All
Insights
Investors
Board of Directors
Leadership
Uncategorized
Our Partners
Scientific Advisory Committee
Cliffs Notes
Trail Notes
Publications
Newsroom
Filter by Quarter
3Q 2021
4Q 2021
1Q 2022
2Q 2022
2Q 2021
1Q 2021
4Q 2020
3Q 2020
Load More
July 11, 2021
Manuscripts
Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors
Denlinger et al., Investigational New Drugs 2021
Read More
Load More